Introduction {#Sec1}
============

Bone defects are a major problem in orthopaedic surgery. The gold standard for defect filling is the use of autogenic bony material. Due to complications associated with the harvesting of autogenic material ([@CR28]; [@CR30]; [@CR31]), allogenic or alloplastic materials might be an alternative grafting material. In the ideal case, this material is biocompatible, not infective, resorbable, osteoconductive, and osteoinductive. Osteoconduction means that bone growth onto a surface or into a given three-dimensional structure ([@CR1]). Osteoinduction is a necessary process for bone formation because it describes the recruitment of undifferentiated pluripotent cells and their stimulation to differentiate into bone forming cells ([@CR1]). Allogenic grafts fulfil the demand of osteoconductivity. These grafts can either be cancellous or cortical in nature. Both variants allow the revascularization and the migration of bone forming and resorbing cells onto and into the tissue ([@CR25]; [@CR33]; [@CR34]). Therefore, the graft serves as a structure for new bone formation. Osteoinduction is a further necessary process for optimal graft ingrowth. Growth factors such as IGF-I, TGF-*β*1, VEGF, etc, are osteoinductive and promote bone formation ([@CR4]; [@CR16]; [@CR17]; [@CR29]). The tissue processing of the grafts such as sterilization, however, might influence the growth factors.

Methods for inactivation of bacteria and viruses use ethylene oxide (EtO), gamma irradiation ([@CR5]) or thermal treatment with moist heat ([@CR9]; [@CR11]). A possible reduction of the osteoinductive potential by ethylene oxide sterilization is under controversial discussion ([@CR2]; [@CR36]; [@CR39]). Starting in 1967 EtO was replaced by the use of beta-propiolactone ([@CR6]) and gamma radiation of 25 kGy (International Atomic Energy Agency [@CR11]). Gamma irradiation, however, might promote the formation of toxic radicals and have a negative effect on biochemical parameters ([@CR19]; [@CR26]). Since beta-propiolactone sterilization also showed, to an increasing extent, problems such as toxicity, a new process on a low-pressure basis, i.e., peracetic acid-ethanol sterilization (PES) ([@CR32]; [@CR38]), was introduced ([@CR37]). The PES treatment for allogenic avital bony tissue is a reliable sterilization method ([@CR22]). Several studies validated the efficacy of this method on selected viruses, bacteria, fungi, and spores and compared this method with other sterilization method ([@CR23]; [@CR22]).

Haynert, Thielecke et al., and Kuhls et al. studied in the framework of clinical feasibility studies the osteoinductive capabilities or integrating ratios of PES sterilized dematerialized bone matrix (DBM) ([@CR8]; [@CR14]; [@CR35]). It was reported unanimously that the PES does not cause any significant reductions of the osteoinductive effects and that the transplanted DBM shows excellent integrating results. A retrospective report of clinical experience of the years 1997--2001 on the overall scope of tissue grafts (total of 16,823 transplants) showed a good up to very good clinical efficacy without clinically relevant side effects ([@CR24]). Goal of the present study was to quantify growth factors necessary for bone formation in PES sterilized allograft material using different extraction methods.

Materials and methods {#Sec2}
=====================

Samples {#Sec3}
-------

Allografts (*n* = 9) were provided by the tissue bank of the Charité. Potential bone tissue donors were clinically examined for a variety of infectious diseases. The approved material was processed with the PES procedure (PES) for allogenic avital bone transplants as described previously ([@CR23]). Briefly, the chloroform-methanol defatted bony material was incubated at low pressure (200 mbar) at room temperature for 4 h under agitation in 2% peracetic acid, 96% ethanol, Aqua (2:1:1).

Demographic data of the donors: 5 male, age: 43 ± 19.4 (18-67 years); 4 female, age: 52.3 ± 10.6 (40--66 years).Fromall donors thefemora were used.

Sample preparation {#Sec4}
------------------

The sterile allografts were pulverized using a cooled mill (Retsch, Germany). The homogenized bony material was diluted in accordance to one the following procedures. Collagenase Extraction: One gram sample was placed in 15 ml centrifuge tubes, and covered with 3 ml of 20 mM Tris buffer plus 20 U/ml Collagenase Type 1. After incubation at 37°C in a shaking water bath over night the tubes were centrifuged for 20 min at 12,000 rpm. After centrifugation, the supernatant was dialyzed against aqua dest over night at 4°C with three changes and thereafter stored at − 80°C (modified after ([@CR3]; [@CR15])).Proteinase Inhibitor (Complete): Two gram sample was incubated for 2 h with 5 ml Proteinase inhibitor (Complete, Roche, Mannheim, Germany) at 4°C. After extraction the samples were centrifuged by 12,000 rpm for 10 min and the supernatant was stored at − 80°C.Guanidine HCl/EDTA method: Thirty milligram of sample were placed in 1.5 ml Eppendorf tubes with 1.9 ml 4 M Guanidine HCl, 50 mM EDTA in 50 ml Tris pH 7.4 plus 5 mM benzamidine-HCl, 1 mM phenylmethylsulfonyl, and 0.1 mM aminocaproic acid. The samples were dialyzed against aqua dest at 4°C for 24 h with four changes (modified after ([@CR20]; [@CR27])).

After extraction the samples were centrifuged by 12,000 rpm and the supernatant was stored at − 80°C.

Protein and growth factor quantification {#Sec5}
----------------------------------------

To quantify the total protein concentration a Coomassie Plus Protein Assay (Pierce, Perbio Science GmbH, Germany) was used. IGF-I, TGF-*β*1, BMP-2, BMP-4, PDGFbb, FGFa, FGFb, and VEGF concentration in the extracts were quantified using ELISA-methods (all kits were obtained from RsD-Systems, Wiesbaden, Germany). The analyses were performed according to the instructions of the manufacturer. Briefly, samples and standards were added to growth factor antibody coated 96 well plates. After incubation and removal of the unbound substances an enzyme coupled secondary antibody was added. This step was followed by a further washing step and incubated with a substrate. The color reaction was stopped and the optical density measured at the appropriate wavelength. If necessary, samples were pretreated as mentioned in the manufactures instructions.

Statistical analysis {#Sec6}
--------------------

The values are reported as mean ± SD. In the case that no growth factor value was determined with the ELISA, the sample was excluded from further statistical evaluation (see Table [1](#Tab1){ref-type="table"}). Comparison of data was performed using ANOVA for global comparison and controlled with Bonferroni correction for multiple testing. Statistical differences were defined at a 95% confidence level. SPSS (release 12.0; SPSS Inc. Chicago, Illinois) software supported statistical evaluation. Table 1Number of allografts in which the growth factors were detectableProteinBMP-2IGF-IVEGFFGFaTGF-β1PDGFBMP-4Collagenase92846370Complete92968167GndHCl99958280

Results {#Sec7}
=======

From eight analyzed growth factors were seven detectable in the allografts (FGFb was not detectable). From the detectable seven growth factors not all the factors were measurable in every allograft (Table [1](#Tab1){ref-type="table"}). A relation of these differences in respect to donor age or gender was not accessible.

Total protein {#Sec8}
-------------

The nine allografts were homogenized in the same way. The proteins were extracted using three different methods: extraction with Collagenase digestion, incubation in PBS with proteinase inhibitor (Complete), or with the guanidine HCl method. Significantly more protein per g tissue was extracted using the guanidine HCl method (Fig. [1](#Fig1){ref-type="fig"}). Almost 10 mg protein was extracted from 1 g sample with this method. This is 24 times more compared to the Complete and 39 times more compared to the Collagenase method. Due to the differences in the extraction efficacy, the following growth factor data were normalized to the protein content of the samples. Fig. 1Protein content per gram sample. Significantly more protein was extracted from the samples after GndHCl extraction compared to both other methods, \**P* \< 0.001

Quantification of growth factors {#Sec9}
--------------------------------

The growth factor BMP-4 was only detectable after the extraction with the Complete method. In seven of nine samples BMP-4 was measurable with an average value of 0.17 pg/µg protein and a SD of 0.06 pg/µg (see Table [2](#Tab2){ref-type="table"}, per g allograft). Table 2Growth factors quantity compared to tissue weight (g allograft)BMP-2 (pg/g)IGF-I (pg/g)VEGF (pg/g)FGFa (pg/g)TGF-β1 (pg/g)PDGF (pg/g)BMP-4 (pg/g)Collagenase431.7 ± 38.31097.9 ± 150.31325.4 ± 556.0105.3 ± 43.146.3 ± 52.010.0 ± 4.3n.d.Complete581.2 ± 100.41434.1 ± 284.81081.3 ± 716.8110.2 ± 89.5203.413.0 ± 7.770.6 ± 18.4GndHCl3778.5 ± 1389.3 ng/g17102.1 ± 2648.71380.9 ± 186.718850.8 ± 8416.62809.1 ± 2725.6245.5 ± 128.3n.d.n.d., Not detectable

The highest growth factor value compared to total protein was detectable for BMP-2. After GndHCl extraction 450 ± 273 pg BMP-2 per lg protein were measured (Fig. [2](#Fig2){ref-type="fig"}). This value was dramatically higher compared to the value assessed after Collagenase (1.5 ± 0.7 pg/lg) or Complete extraction (1.9 ± 1.07 pg/lg). Using the GndHCl method in all nine allografts BMP-2 was detectable whereas in both other methods only in two allografts, therefore, the difference was not significant. The level of IGF-I and VEGF were significantly higher after Collagenase extraction compared to the GndHCl method (Figs. [3](#Fig3){ref-type="fig"}, [4](#Fig4){ref-type="fig"}). In contrast, FGFa revealed a significantly higher value after GndHCl extraction compared to both other methods (Fig. [5](#Fig5){ref-type="fig"}). No significant differences were measurable for the growth factors TGF-*β*1 and PDGF (Figs. [6](#Fig6){ref-type="fig"}, [7](#Fig7){ref-type="fig"}). TGF-*β*1 was detectable only in one to three of nine samples with the three different methods. Not all method extracted TGF-*β*1 from the same samples (Table [1](#Tab1){ref-type="table"}). Fig. 2Quantification of BMP-2 \[pg/µg Protein\] in allografts using three different extraction methods. The BMP- 2 content is correlated to the total protein content of the samples. Using the Collagenase or the Complete Method in only two of nine samples was BMP-2 detectableFig. 3Quantification of IGF-I \[pg/µ Protein\] in allografts using three different extraction methods, \**P* = 0.003 compared to GndHClFig. 4Quantification of VEGF \[pg/µ Protein\] in allografts using three different extraction methods, \**P* = 0.014 compared to GndHClFig. 5Quantification of FGFa \[pg/µg Protein\] in allografts using three different extraction methods, \**P* \< 0.001 compared to both methodsFig. 6Quantification of TGF-*β*1 \[pg/µg Protein\] in allografts using three different extraction methodsFig. 7Quantification of PDGF \[pg/µg Protein\] in allografts using three different extraction methods

Discussion {#Sec10}
==========

One important question using allografts for bone defect filling is the content of growth factors in the graft material. Therefore, aim of this study was the quantification of growth factors in PES sterilized allografts.

From the eight investigated growth factors seven were detectable in the allografts: BMP-2, BMP-4, IGF-I, VEGF, FGFa, TGF-*β*1, and PDGF. FGFb was not detectable in any sample.

Three different methods for protein extraction were used which also differ in the handling and the preparation time. The elution of the homogenized bony material in PBS plus proteinase inhibitor (Complete) is very easy and fast. The two other methods---collagenase digestion ([@CR3]; [@CR15]) and guanidine HCl extraction ([@CR20]; [@CR27])---are time consuming and laborious. Significant differences were found in the amount of extracted total protein. The highest value was obtained with the guanidine HCl method (app. 10 mg/g sample). With the two other methods significant but comparable lower values were measured. Differences were also detectable in the amount of the measured growth factors. To overcome the differences in the extraction efficacy, we normalized the growth factor content to the total protein value obtained by each method. BMP-4, however, was only detectable after PBS and proteinase inhibitor extraction (Complete method).A nearly comparable succession of growth factors was obtained with the three methods but significant differences were measurable in the value of the individual growth factors depending on the extraction method. The highest BMP-2 value was obtained after GndHCl extraction. The GndHCl extraction showed also for FGFa the highest extraction value compared to both other methods. Using the Collagenase digestion, IGF-I and VEGF were extractable in a significantly higher value compared to the GndHCl method. These results clearly demonstrate the importance of the extraction method. A comparison of growth factor values is only possible, when the same extraction protocols were used.

The study shows that using the guanidine extraction method significantly more protein can be extracted. This method however is time consuming and needs much more different chemicals. For a comparison of growth factors or different materials we can recommend the easy and fast proteinase method. This is the first study that quantified growth factors in allografts. The limitations of the study are that it is hardly possible to make a conclusion, if these detected amounts are sufficient to induce new bone formation and that the bioactivity was not tested. The quantification with ELISA method gives no information concerning the bioactivity of the growth factors. A 2005 published study by Honsawek, however, showed a good correlation between the osteoinductivity of demineralized bone matrix (DBM) and the BMP-4 content measured by ELISA method ([@CR10]). DBMs with high BMP-4 level demonstrated the highest osteoinductivity in the mouse bioassay. In addition, several studies were able to demonstrate an osteoinductive potential of allografts ([@CR13]; [@CR18]; [@CR21]). Hansen et al. used PES-sterilized demineralized bone matrix for filling of critical size craniotomy defects. Compared to the unfilled defects, they describe bone defect bridging by newly formed woven bone with incorporated DBM residues on day 84 ([@CR7]). These results, taken together with the quantification of growth factors in human allografts, support the hypothesis that allografts have an osteoinductive potential and promote the graft incorporation. However, further in vivo and in vitro investigation on the bioactivity of the detected growths factors in the allograft should be performed.
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BMP

:   Bone morphogenetic growth factor

DBM

:   Demineralized bone matrix

ELISA

:   Enzyme linked immunosorbant assay

FGF

:   Fibroblast growth factor

GndHCL

:   Guanidine HCl

IGF-I

:   Insulin like growth factor-I

PBS

:   Phosphate buffered saline

PES

:   Peracetic acid-ethanol sterilization

PDGF

:   Platelet derived growth factor

TGF-β1

:   Transforming growth factor-beta1

VEGF

:   Vascular endothelial growth factor
